News Articles

BNAC in the Spotlight at ECTRIMS 2023

Wednesday, January 3rd, 2024

The Buffalo Neuroimaging Analysis Center (BNAC) enjoyed the spotlight at the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2023 where its researchers were recognized for an unprecedented array of publications that are shaping the field of neuroimaging in multiple sclerosis (pwMS) and related disorders.

Advancements and Challenges in Multiple Sclerosis: A Comprehensive Review in Lancet

Monday, November 27th, 2023

Recent advancements in multiple sclerosis (MS) research, including improved diagnostic criteria and novel MRI techniques, have been highlighted in a new Lancet paper by researchers from the Buffalo Neuroimaging Analysis Center (BNAC) and the Jacobs MS Center for Treatment and Research.

BNAC Celebrates New Headquarters at Grand Opening

Wednesday, November 1st, 2023

On October 5th Buffalo Neuroimaging Analysis Center celebrated the opening of its new headquarters located at the University at Buffalo's Downtown Gateway Building.

Possibilities of Measuring Cognitive Progression Independent of Relapses in MS: Tom Fuchs, MD, PhD

Monday, October 23rd, 2023

At MSMilan 2023, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy, Tom Fuchs, MD, PhD, presented in a scientific session on the effects of MS on cognition, including cognitive progression independent of relapse activity.

Grand Opening of BNACs New Offices

Wednesday, September 6th, 2023

Buffalo Neuroimaging Analysis Center presents the Grand Opening of our New Offices on October 5th, 2023.

MRI Scanner Launches New Biomedical Imaging Era at UB

Friday, September 1st, 2023

The massive 5.5-ton Philips MR 7700 that was installed in June in the Center for Biomedical Imaging (CBI) in UB’s Clinical and Translational Research Center (CTRC) is now operational.

‘One of the world’s most advanced scanners’: What UB researchers need to know

Thursday, August 3rd, 2023

The June delivery of a Philips MR 7700 to the Clinical and Translational Research Center (CTRC) was called “a major advance in our translational research environment” by University at Buffalo Clinical and Translational Science Institute (CTSI) Director Timothy F. Murphy, MD. And for researchers at the University at Buffalo and Buffalo Translational Consortium, the impact of the 5-ton, 3-Tesla magnetic resonance imaging (MRI) scanner looks to be momentous.

Researcher Spotlight: Ferdinand Schweser, Ph.D.

Monday, July 31st, 2023

Associate Professor of Neurology, Radiology, and Biomedical Engineering at the University at Buffalo, Ferdinand Schweser, Ph.D, is a member of BNAC’s leadership team and continues to make significant contributions to the field of neuroimaging. His expertise lies in the MRI technique called quantitative susceptibility mapping (QSM) and its application in studying the relationship between brain iron and MS.

BNAC Summer 2023 Newsletter

Monday, July 31st, 2023

Links Between Eye Measurements and Brain Function in People with Multiple Sclerosis Point to Possible Biomarker for Cognitive Performance

Thursday, July 6th, 2023

Retinal nerve fiber thickness may serve as a potential biomarker for cognitive impairment in people with MS, possibly predicting future cognitive decline.

Study Reveals How Brain Organization Changes in Progressive MS

Thursday, June 29th, 2023

A recent study conducted by a BNAC research team led by Alexander Bartnik showed that, in people with multiple sclerosis, the brain networks involved in more complex thinking were more impaired than networks related to basic senses, like vision and hearing.

Choroid Plexus Inflammation May Affect Disability Progression Over 5 Years in People With Multiple Sclerosis

Tuesday, May 30th, 2023

BNAC Researcher Niels Bergsland recently led a new study that indicates inflammation in the choroid plexus – a complex network of capillaries that produces cerebrospinal fluid in the brain – may affect disease progression and disability in people living with MS. 

BNAC Director Robert Zivadinov Wins Highest Faculty Honor as SUNY Distinguished Professor

Tuesday, May 23rd, 2023

Robert Zivadinov, MD, Ph.D., has been named a SUNY Distinguished Professor – the highest faculty honor in the State University of New York (SUNY) system.

Novel MRI Technique Predicts Staging of Paramagnetic Rim Lesions

Monday, March 13th, 2023

BNAC researchers develop a novel MRI technique that predicts staging of Paramagnetic Rim Lesions, a biomarker of chronic brain inflammation believed to be associated with progressive MS. They presented their work at ACTRIMS Forum 2023.

'Usual Suspect’ lesions appear not to cause most severe disability in MS patients

Friday, February 24th, 2023

Groundbreaking BNAC study shows that keys to severe disability in multiple sclerosis are cortical, deep gray matter, and spinal cord damage rather than lesions.

2022 Annual BNAC Newsletter

Thursday, December 22nd, 2022

Each year, we share highlights of our patient-centered research, news about our scientists, core laboratory services, and our many collaborations at the Buffalo Neuroimaging Analysis Center. Thank you for taking an interest in our work. As always, we welcome your inquiries, comments, and suggestions and invite you to stay in touch with our progress on the developments that matter most to you.

LINDA J. SAFRAN, CFRE, MARKS 14 YEARS OF EXTRAORDINARY SERVICE TO BNAC AND PEOPLE WITH MS

Thursday, November 17th, 2022

Smart. Creative. Indefatigable. Optimist. There certainly are more ways to describe BNAC’s long-time friend and fundraising consultant, Linda J. Safran. Yet none may be more descriptive than commitment. 

MS clinicians listen up: Here’s how your patients need you to talk about brain atrophy.

Monday, November 14th, 2022

Neuroimaging researchers, providers and people with MS collaborated to develop novel guidelines on how to communicate about brain atrophy .

BNAC RESEARCHERS, STUDENTS RECOGNIZED FOR EXCELLENCE

Thursday, August 11th, 2022

Recently, several members of the BNAC team and their mentees have been honored by colleagues, the University at Buffalo, and the broader scientific community for exceptional work.

Celebrating the Life and Legacy of MS Pioneer and BNAC Founder Dr. Larry Jacobs

Wednesday, August 10th, 2022

BNAC researchers and students join in celebrating the life and work of the late Lawrence Jacobs, BNAC founder and a brilliant and visionary biomedical researcher whose research changed forever how multiple sclerosis was treated around the world.